US12359234B2ActiveUtilityA1
Oligosaccharide production in yeast cells expressing an ABC transporter protein
Est. expiryAug 13, 2039(~13 yrs left)· nominal 20-yr term from priority
C12Y 501/03014C12Y 402/01047C12Y 306/03C12Y 207/07043C12Y 207/07023C12Y 205/01057C12Y 204/99004C12Y 204/01152C12Y 204/01069C12Y 101/01271C12R 2001/865C07K 14/395C07K 14/37C12P 19/04
57
PatentIndex Score
0
Cited by
11
References
9
Claims
Abstract
Provided herein are genetically modified yeast cells capable of producing one or more human milk oligosaccharides (HMOs) and methods of making such cells. The yeast cells are engineered to comprise a heterologous nucleic acid encoding a transporter protein and one or more heterologous nucleic acids that encode enzymes of a HMO biosynthetic pathway. Also provided are fermentation compositions including the disclosed genetically modified yeast cells, and related methods of producing and recovering HMOs generated by the yeast cells.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A yeast cell genetically modified to produce one or more human milk oligosaccharides, wherein the yeast cell comprises (i) a heterologous nucleic acid encoding a human milk oligosaccharide (HMO) ABC transporter polypeptide; and (ii) one or more heterologous nucleic acids that each independently encode at least one enzyme of a human milk oligosaccharide biosynthetic pathway.
2. The yeast cell of claim 1 , wherein the ABC transporter exports the human milk oligosaccharide 2′-fucosyllactose.
3. The yeast cell of claim 1 , wherein the ABC transporter has at least 95% identity to any one of SEQ ID NOS: 1-27.
4. The yeast cell of claim 3 , wherein the ABC transporter has at least 95% identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3.
5. The yeast cell of claim 1 , wherein the one or more human milk oligosaccharides comprise 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, 3′-sialyllactose, 6′-sialyllactose, and/or difucosyllactose.
6. The yeast cell of claim 5 , wherein the enzymes encoded by the one or more heterologous nucleic acids that independently encode at least one enzyme of the human milk oligosaccharide biosynthetic pathway comprise one or more of a GDP-mannose 4,6-dehydratase, a GDP-L-fucose synthase, an α-1,2-fucosyltransferase, a fucosidase, β-1,3-N-acetylglucosaminyltransferase, a β-1,3-galactosyltransferase, a UDP-N-acetylglucosamine diphosphorylase, a β-1,4-galactosyltransferase, a CMP-Neu5Ac synthetase, a sialic acid synthase, a UDP-N-acetylglucosamine 2-epimerase, a CMP-N-acetylneuraminate-β-galactosamide-α-2,3-sialyltransferase, and an α-1,3-fucosyltransferase.
7. The yeast cell of claim 1 , wherein the enzymes encoded by the one or more heterologous nucleic acids further comprise a protein that transports lactose into the yeast cell.
8. A method of producing one or more human milk oligosaccharides, the method comprising culturing a population of genetically modified yeast cells of claim 1 in a culture medium under conditions suitable for the yeast cells to produce the one or more human milk oligosaccharides.
9. A fermentation composition comprising:
a population of genetically modified yeast cells comprising the yeast cell of claim 1 ; and a culture medium comprising one or more human milk oligosaccharides produced from the yeast cells.Join the waitlist — get patent alerts
Track US12359234B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.